Atlas Trials

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Clinical trial NCT00090493 · COMPLETED

Trial details

NCT number
NCT00090493
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2004-06-01
Primary completion
2007-07-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.